AarogyaAIÂ® Rapid Tuberculosis Drug Sensitivity Test

Acces sibility Controls

Implementing Organization

About

A combined approach with whole genome sequencing and artificial intelligence, towards combating antimicrobial resistance in tuberculosis, by generating a comprehensive drug susceptibility report for individual patients, a 100X faster than existing solutions.

Patents

Outcome / Output

There is a dearth of tools in the market that can provide a rapid and comprehensive diagnosis of drug-resistant tuberculosis. Hence, AarogyaAI®’s algorithm is extremely relevant as it provides a comprehensive precision drug susceptibility report for the patients, based on the genome of the M. tb infecting the patient.

Source

Source URL

technologies/aarogyaaiâ®-rapid-tuberculosis-drug-sensitivity-test

Related Research

View All

Quick Information

Thrust Areas

Medical Sciences

Focus Area

COPD, Healthcare

Sanction Amount

₹ 1. AAICARE-TB: Rs. 5,500/- 2. AAICARE-AMR: Rs. 10,000/- 3. AAICARE-XYZ (Customised pipeline): Rs. 15,000/-

Status

Pilot Study completed

Acces sibility Controls

Medical Sciences